Model 3, the fully adjusted model, demonstrated that each one-unit increase in PRL did not significantly alter the odds of CV events in men with a history of CKD compared to those without (OR: 0.9; 95% CI: 0.9–1.0). Here, PRL is linked to chronic kidney disease.